Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial
- Resource Type
- Article
- Source
- In
Clinical Breast Cancer June 2022 22(4):308-318 - Subject
- Language
- ISSN
- 1526-8209